Nouvelles de la Bourse
Dernières actualités financières · Mis à jour Jul 28, 2026
Leerink Partners relève l'objectif de cours d'Oruka Therapeutics, Inc. (ORKA)
Leerink Partners Lifts PT on Oruka Therapeutics, Inc. (ORKA)
ORKA-001's Phase 2a results are impressive, but its path to market is uncertain due to manufacturing challenges, competition, and commercial …
AnaptysBio (ANAB) est-elle l'une des actions de soins de santé les plus performantes jusqu'à présent en 2026 ?
Is AnaptysBio (ANAB) One of the Best Performing Healthcare Stocks so Far in 2026?
The panel is divided on ANAB's spinoff of TRAX, with some seeing it as a value-enhancing move that separates stable …
Revolution Medicines (RVMD) reçoit la lettre "Safe to Proceed" de la FDA pour le daraxonrasib
Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib
The panel is mixed on RVMD's 'safe to proceed' EAP, with concerns about the lack of efficacy data, manufacturing challenges, …
RBC Capital relève l'objectif de cours d'Acadia Healthcare Company (ACHC) suite à une meilleure performance que prévu au T1
RBC Capital Lifts PT on Acadia Healthcare Company (ACHC) Following Q1 Earnings Beat
While ACHC's Q1 earnings beat and upgrades suggest potential for EBITDA improvement and a 'harvest' from underperforming facilities, the consensus …
Twist Bioscience Corporation (TWST) annonce ses résultats financiers du T2 2026
Twist Bioscience Corporation (TWST) Announces Q2 2026 Financial Results
The panelists agree that Twist Bioscience has shown operational momentum with 13 consecutive quarters of growth and a 19% YoY …
Goldman Sachs réinitialise les prévisions de Broadcom
Goldman Sachs resets Broadcom stock forecast
The panel is divided on Broadcom's VMware integration, with bulls focusing on potential margin expansion and AI momentum, while bears …
RBC Capital augmente le PT sur CG Oncology (CGON), appelle PIVOT-006 un catalyseur complexe
RBC Capital Lifts PT on CG Oncology (CGON), Calls PIVOT-006 a Complex Catalyst
CG Oncology's stock performance is heavily reliant on the June PIVOT-006 data, with a high risk of a 'sell the …
W.W. Grainger Faits saillants de l'appel sur les résultats du T1
W.W. Grainger Q1 Earnings Call Highlights
Panelists have mixed views on Grainger's Q1 results and future prospects. While some highlight the impressive EPS growth and margin …
Les actions européennes devraient ouvrir sur une note prudente
European Shares Seen Opening On Cautious Note
The panelists generally agree that European stocks face headwinds due to stretched valuations and uncertainty around central bank policies, with …
Le bénéfice du premier trimestre de Hanwha Life Insurance augmente grâce à la croissance des ventes ; les actions en hausse
Hanwha Life Insurance Q1 Profit Climbs On Sales Growth; Shares Up
Hanwha Life's impressive Q1 results, with net income up 43.5% and sales surging 54.7%, are being scrutinized due to a …
Ce titre de puce sous-évalué vient de faire quelque chose qu'il n'a pas fait depuis un an. Est-ce le moment d'acheter ?
This Beaten-Down Chip Stock Just Did Something It Hasn't Done in a Year. Time to Buy?
Despite positive Q2 guidance, Impinj's high forward P/E multiple (74x) is seen as unsustainable by most panelists, who caution against …
Les bénéfices de Kawasaki Heavy Industries pour l'exercice 25 augmentent, prévoit une croissance pour l'exercice 26 ; l'action gagne
Kawasaki Heavy Industries FY25 Profit Climbs, Sees Growth In FY26; Stock Gains
Despite strong revenue growth, Kawasaki Heavy's guidance for significantly slower net profit growth raises concerns about margin sustainability. The market …